The FDA is signaling a narrower definition of “dietary supplement” that could sideline innovative natural products and limit consumer choice—unless it’s challenged.
Listen to the audio version of this article:
THE TOPLINE
- The FDA is considering a narrow interpretation of “dietary substance” that could exclude many natural, traditional, and innovative ingredients from qualifying as dietary supplements.
- This shift could push a wide range of products into regulatory limbo or the costly drug approval pipeline, reducing access and favoring pharmaceutical pathways.
- ANH is urging the FDA to follow the law as written, prioritize safety over restriction, and preserve consumer access to a broad range of health-supporting products.
What if the FDA could quietly redefine supplements in a way that puts many of your go-to health products out of reach?
At a time when Americans are facing a chronic disease crisis of historic proportions, you’d think federal regulators would be doing everything possible to expand access to safe, health-promoting tools. Instead, the FDA is moving in the opposite direction—quietly advancing an interpretation of the law that could restrict access to a wide range of dietary supplements.
That’s why ANH-USA has stepped in.
In a recent regulatory submission, ANH urged the FDA to stick to the law as written and reject efforts to narrow what qualifies as a “dietary supplement.” At stake is your ability to access innovative, natural products that can support your health.
What’s the Fight About?
The issue centers on how the FDA defines a “dietary substance”—a key part of the legal definition of a dietary supplement. Congress intentionally wrote this definition broadly in the Dietary Supplement Health and Education Act (DSHEA) of 1994 to ensure consumers would have access to a wide variety of safe products.
Section 201(ff)(1) defines a “dietary supplement” as a product, other than tobacco, intended to supplement the diet and bearing or containing one or more dietary ingredients, including vitamins, minerals, herbs or other botanicals, amino acids, “a dietary substance for use by man to supplement the diet by increasing the total dietary intake,” or a concentrate, metabolite, constituent, extract, or combination of such ingredients.
The FDA is signaling it may interpret the “dietary substance” portion of the definition (bolded above) narrowly—essentially limiting it to substances already commonly consumed in the typical American diet.
Why This Matters
If the FDA adopts this narrow view, it could shut the door on a huge range of beneficial ingredients, including:
- Compounds used in traditional diets from around the world
- Concentrated forms of naturally occurring nutrients
- Innovative ingredients produced through modern, safe technologies
- Emerging natural compounds that support health but aren’t part of the standard American diet
In other words, many of the most promising tools for improving health could be pushed out of the supplement category altogether and into a regulatory limbo—or worse, into the drug approval pipeline, where costs and barriers are so high that only pharmaceutical companies can compete.
The Bigger Picture
Why is the FDA doing this – especially now, while HHS Secretary Kennedy and FDA Commissioner Makary are ostensibly in charge? Dietary supplements are overwhelmingly safe. Serious adverse events are extremely rare—especially compared to pharmaceuticals. Yet the FDA stance appears unchanged under Kennedy and Makary’s leadership, the agency consistently adopting an aggressive posture towards supplements with the goal of not just limiting access, but creating the impression that supplements are not a legitimate way to maintain health. That’s what drugs are for!
A Better Approach
ANH is not arguing for a free-for-all. Safety and transparency matter. Bad products should be removed from the market.
But the law already gives the FDA the tools it needs to do that.
What ANH is advocating for is simple:
- Follow the statute: Congress deliberately created a broad definition that isn’t limited to constituents of the standard American diet.
- Focus on safety, not restriction: Evaluate whether products are safe, rather than excluding them outright.
- Allow innovation: New technologies and ingredients should be judged on their merits, not dismissed because they’re new.
- Protect consumer choice: People should have access to a wide range of safe options to support their health.
- Preserve our Constitutional rights: First Amendment protections should enable consumers to have full access to relevant health information about natural health products to allow them to make informed choices.
Why Now?
We are living through a surge in chronic illness—conditions like obesity, diabetes, and heart disease that are often preventable or manageable with better nutrition and lifestyle choices.
Dietary supplements can play a critical role in that effort. They’re not a cure-all, but they are an important part of a broader strategy to stay healthy and reduce reliance on drugs.
Restricting access to these tools at this moment is misguided and counterproductive.
The Bottom Line
This debate may sound technical, but its impact is very real.
A narrow definition of “dietary substance” means fewer choices, less innovation, and more barriers between you and the tools you use to stay healthy.
ANH is pushing back to ensure that doesn’t happen. In a country struggling with chronic disease, the last thing we need is less access to safe, effective, natural health solutions.
Please share this article widely in your network.
